Abzyme Files Patent Application for Self-Diversifying Antibody Platform
Abzyme Therapeutics LLC, a biotechnology company focused on developing antibodies for diagnostic and therapeutic applications, has filed a patent application entitled "Composition and Method for Diversifying Polypeptide Libraries," USPTO number 62/387,511. This is an important milestone... - August 03, 2017
Press Releases 1 - 1 of 1